Canada markets closed

Innovent Biologics, Inc. (6IB.F)

Frankfurt - Frankfurt Delayed Price. Currency in EUR
Add to watchlist
4.0400+0.0200 (+0.50%)
At close: 03:29PM CEST
Show:
Income Statement
Cash Flow
Annual

Balance Sheet

All numbers in thousands
Breakdown
2023-12-31
2022-12-31
2021-12-31
2020-12-31
2019-12-31
Assets
Current Assets
Cash
Cash And Cash Equivalents
2,745,693
1,016,165
8,377,095
1,276,178
-
Other Short Term Investments
7,374,088
7,248,429
638,213
6,771,952
-
Total Cash
10,119,781
8,264,594
9,015,308
8,048,130
-
Net Receivables
1,005,891
575,269
968,405
475,378
-
Inventory
968,088
1,428,882
1,347,240
705,658
-
Total Current Assets
13,427,985
11,506,708
11,550,849
9,466,681
-
Non-current assets
Property, plant and equipment
Gross property, plant and equipment
5,887,530
4,821,277
3,892,583
2,536,766
-
Accumulated Depreciation
-1,035,627
-760,558
-516,826
-353,285
-
Net property, plant and equipment
4,851,903
4,060,719
3,375,757
2,183,481
-
Intangible Assets
1,270,267
1,198,163
772,194
32,625
-
Total non-current assets
7,199,375
6,082,137
4,692,864
2,368,315
-
Total Assets
20,627,360
17,588,845
16,243,713
11,834,996
-
Liabilities and stockholders' equity
Liabilities
Current Liabilities
Current Debt
1,195,155
888,000
365,000
255,000
-
Accounts Payable
372,549
325,622
195,050
120,620
-
Total Current Liabilities
4,476,816
3,499,198
3,050,047
1,485,851
-
Non-current liabilities
Long Term Debt
2,326,777
2,215,433
2,023,261
925,178
-
Deferred revenues
960,051
883,277
753,274
633,964
-
Other long-term liabilities
-
-
-
-
16,518
Total non-current liabilities
3,622,963
3,359,698
2,863,269
1,569,375
-
Total Liabilities
8,099,779
6,858,896
5,913,316
3,055,226
-
Stockholders' Equity
Common Stock
112
105
101
97
-
Retained Earnings
-15,767,568
-14,739,655
-
-
-
Total stockholders' equity
12,527,581
10,729,949
10,330,397
8,779,770
-
Total liabilities and stockholders' equity
20,627,360
17,588,845
16,243,713
11,834,996
-